A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Tesla (T) magnetic resonance imaging (MRI) changes management in more than half of adult candidates for epilepsy surgery.

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

Gyratory seizures are rare neurological episodes causing involuntary, forceful body rotation, often linked to frontal lobe ...

Just before Harmoni Jones turned four years old, her preschool teacher alerted Harmoni’s mother, Deantonecia Jones, that the ...

For nearly one-third of the 3 million adults in the United States living with epilepsy, medications fail to control seizures.

Results from the open-label extension portion of the Pacific trial saw bexicaserin able to elicit seizure reduction in ...

B was first diagnosed with Lennox-Gastaut syndrome (LGS) due to the frequency and severity of his seizures. He was later ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Epilepsy affects about 50 million people worldwide, making it one of the most common neurological disorders. In India, nearly ...